Filing Details

Accession Number:
0001140361-13-008208
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-19 19:23:33
Reporting Period:
2013-02-14
Filing Date:
2013-02-19
Accepted Time:
2013-02-19 19:23:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1184151 R Conan Deady One Idexx Drive
Westbrook ME 04092
Corp Vp, General Counsel & Sec No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-02-14 3,449 $56.95 4,631 No 4 M Direct
Common Stock Acquisiton 2013-02-14 2,401 $77.59 7,032 No 4 M Direct
Common Stock Acquisiton 2013-02-14 3,772 $34.37 10,804 No 4 M Direct
Common Stock Disposition 2013-02-14 9,622 $92.04 1,182 No 4 S Direct
Common Stock Acquisiton 2013-02-14 243 $0.00 1,425 No 4 M Direct
Common Stock Acquisiton 2013-02-14 258 $0.00 1,683 No 4 M Direct
Common Stock Acquisiton 2013-02-14 375 $0.00 2,058 No 4 M Direct
Common Stock Acquisiton 2013-02-14 363 $0.00 2,421 No 4 M Direct
Common Stock Acquisiton 2013-02-14 300 $0.00 2,721 No 4 M Direct
Common Stock Disposition 2013-02-14 496 $91.68 2,225 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-02-14 1,693 $0.00 1,693 $56.95
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-02-14 2,401 $0.00 2,401 $77.59
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-02-14 3,772 $0.00 3,772 $34.37
Common Stock Incentive Stock Option (right to buy) Disposition 2013-02-14 1,756 $0.00 1,756 $56.95
Common Stock Restricted Stock Unit Disposition 2013-02-14 243 $0.00 243 $0.00
Common Stock Restricted Stock Unit Disposition 2013-02-14 258 $0.00 258 $0.00
Common Stock Restricted Stock Unit Disposition 2013-02-14 375 $0.00 375 $0.00
Common Stock Restricted Stock Unit Disposition 2013-02-14 363 $0.00 363 $0.00
Common Stock Restricted Stock Unit Disposition 2013-02-14 300 $0.00 300 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-02-13 No 4 M Direct
5,914 2018-02-13 No 4 M Direct
863 2016-02-13 No 4 M Direct
0 2015-02-13 No 4 M Direct
4,154 No 4 M Direct
3,896 No 4 M Direct
3,521 No 4 M Direct
3,158 No 4 M Direct
2,858 No 4 M Direct
Footnotes
  1. The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $92.00 to $92.10, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
  2. Grant of options to buy shares of common stock becomes exercisable as to 3,449 shares on 02/14/2009 and 02/14/2010, 3,448 shares on 02/14/2011 and 02/14/2012, and the remaining 1,693 shares on 02/14/2013.
  3. Grant of options to buy shares of common stock becomes exercisable as to 2,401 shares on 02/14/2012, 02/14/2013, 02/14/2014 and 02/14/2015, and the remaining 1,112 shares on 02/14/2016.
  4. Grant of options to buy shares of common stock becomes exercisable as to 3,772 shares on 02/14/2010 and 02/14/2013, 3,773 shares on 02/14/2011 and 02/14/2012, and the remaining 863 shares on 02/14/2014.
  5. Grant of options to buy shares of common stock becomes exercisable as to 1 share on 02/14/2011, and the remaining 1,755 shares on 02/14/2013.
  6. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.
  7. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.
  8. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.
  9. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2010) of the date of grant.
  10. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.